ArticleAnnals of translational medicine2019

Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma.

Vincenzo Di Nunno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.